DMED — Diagnamed Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- CA$2.90m
- CA$2.79m
- 14
- 16
- 37
- 10
Annual cashflow statement for Diagnamed Holdings, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -1.95 | -1.13 | -1.28 | -0.501 |
| Non-Cash Items | 1.26 | 0.139 | 0.06 | -0.218 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.118 | 0.206 | 0.15 | 0.275 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Cash from Operating Activities | -0.566 | -0.788 | -1.07 | -0.445 |
| Other Investing Cash Flow Items | 0.034 | 0 | — | — |
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 0.034 | 0 | — | — |
| Net Issuance / Retirement of Stock | ||||
| Cash from Financing Activities | 2.89 | 0 | 0.104 | 0 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 2.36 | -0.788 | -0.963 | -0.445 |